Suppr超能文献

解冻后CD34+细胞回收率在极高的移植物血小板浓度下可能会降低。

Post-thaw CD34+ cell recovery likely degraded under extreme graft platelet concentrations.

作者信息

Duarte Gustavo C, Ladvanszky Leandro, Atkinson Gavin, Burns Michelle, Madola Dona, Sadani Deepak, Yan-Fischer Marcus, Patel Hemant, Tremblay Jacynthe, Butler Andrew, Rathod Niranjan, Wei Wen-Hua

机构信息

New Zealand Blood Service, 15 Lester Lane, Christchurch, New Zealand.

New Zealand Blood Service, 71 Great South Road, Auckland, New Zealand.

出版信息

Bone Marrow Transplant. 2024 Dec;59(12):1704-1709. doi: 10.1038/s41409-024-02409-w. Epub 2024 Sep 16.

Abstract

Impaired post-thaw CD34 cell (postCD34) viability in autologous haematopoietic stem cell transplant (ASCT) could indicate delayed engraftment where multiple factors might complicate the relationship. Despite of a couple of unconfirmed reports of a negative correlation of platelet concentration with postCD34 viability, how platelets might be involved in the relationship is largely unknown. Therefore, this question was addressed in this retrospective study of 82 ASCT patients with a total of 150 collections of peripheral blood stem cells in New Zealand. A significant negative correction between platelet concentration and postCD34 recovery (r = -0.18, p = 0.028) was observed overall, but upon further analysis only confirmed in the subset with graft platelets 1500-2000 ×10/L. Importantly, the postCD34 recovery was clearly reduced in the subgroups with either the lowest or the highest platelet concentration. The lowest subgroup was enriched with collections from patients with Hodgkin or non-Hodgkin lymphoma, whereas the highest subgroup from patients with multiple myeloma, both with clearly male preponderance. We hypothesized that graft platelet concentrations probably indicated CD34 cell state (e.g. cell cycle and cell adhesion highly related to platelet functions) that sustained when platelet concentrations were within a niche range but went out of kilter otherwise.

摘要

在自体造血干细胞移植(ASCT)中,解冻后CD34细胞(postCD34)活力受损可能表明植入延迟,而多种因素可能使这种关系变得复杂。尽管有一些未经证实的报告称血小板浓度与postCD34活力呈负相关,但血小板在这种关系中可能如何起作用在很大程度上尚不清楚。因此,在这项对新西兰82例ASCT患者进行的回顾性研究中,共采集了150份外周血干细胞样本,探讨了这个问题。总体上观察到血小板浓度与postCD34恢复之间存在显著的负相关(r = -0.18,p = 0.028),但进一步分析仅在移植血小板为1500 - 2000×10⁹/L的亚组中得到证实。重要的是,在血小板浓度最低或最高的亚组中,postCD34恢复明显降低。血小板浓度最低的亚组中,霍奇金淋巴瘤或非霍奇金淋巴瘤患者的采集样本较多,而血小板浓度最高的亚组中,多发性骨髓瘤患者的采集样本较多,这两个亚组男性均占明显优势。我们推测,移植血小板浓度可能表明了CD34细胞状态(例如与血小板功能高度相关的细胞周期和细胞黏附),当血小板浓度在特定范围内时这种状态得以维持,否则就会失衡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac18/11611725/03629af16fad/41409_2024_2409_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验